Andres Y. Maldonado
Stock Analyst at HC Wainwright & Co.
(4.39)
# 351
Out of 5,116 analysts
25
Total ratings
60.87%
Success rate
19.58%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Y. Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STRO Sutro Biopharma | Maintains: Neutral | $2 → $10 | $11.49 | -12.97% | 1 | Dec 22, 2025 | |
| HOWL Werewolf Therapeutics | Maintains: Buy | $10 → $4 | $0.65 | +511.34% | 1 | Dec 19, 2025 | |
| TERN Terns Pharmaceuticals | Maintains: Buy | $20 → $60 | $41.52 | +44.51% | 2 | Dec 9, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $5.55 | +314.41% | 2 | Dec 3, 2025 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $25 | $9.45 | +164.55% | 1 | Nov 24, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $10 → $7 | $1.06 | +560.38% | 1 | Nov 13, 2025 | |
| SNDX Syndax Pharmaceuticals | Reiterates: Buy | $40 | $21.30 | +87.79% | 2 | Oct 27, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterates: Buy | $40 | $8.33 | +380.19% | 2 | Oct 20, 2025 | |
| MRUS Merus | Downgrades: Neutral | $135 → $97 | $96.92 | +0.08% | 1 | Sep 30, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $23 | $6.01 | +282.70% | 1 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $105 | $68.66 | +52.93% | 2 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $44 | $45.67 | -3.66% | 1 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $39.84 | +88.25% | 3 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $9.50 | +163.16% | 2 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.14 | +273.83% | 1 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $5.87 | +274.79% | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $21.03 | -4.90% | 1 | Aug 8, 2025 |
Sutro Biopharma
Dec 22, 2025
Maintains: Neutral
Price Target: $2 → $10
Current: $11.49
Upside: -12.97%
Werewolf Therapeutics
Dec 19, 2025
Maintains: Buy
Price Target: $10 → $4
Current: $0.65
Upside: +511.34%
Terns Pharmaceuticals
Dec 9, 2025
Maintains: Buy
Price Target: $20 → $60
Current: $41.52
Upside: +44.51%
Protara Therapeutics
Dec 3, 2025
Reiterates: Buy
Price Target: $23
Current: $5.55
Upside: +314.41%
Day One Biopharmaceuticals
Nov 24, 2025
Reiterates: Buy
Price Target: $25
Current: $9.45
Upside: +164.55%
TScan Therapeutics
Nov 13, 2025
Maintains: Buy
Price Target: $10 → $7
Current: $1.06
Upside: +560.38%
Syndax Pharmaceuticals
Oct 27, 2025
Reiterates: Buy
Price Target: $40
Current: $21.30
Upside: +87.79%
Corbus Pharmaceuticals Holdings
Oct 20, 2025
Reiterates: Buy
Price Target: $40
Current: $8.33
Upside: +380.19%
Merus
Sep 30, 2025
Downgrades: Neutral
Price Target: $135 → $97
Current: $96.92
Upside: +0.08%
Candel Therapeutics
Sep 29, 2025
Reiterates: Buy
Price Target: $23
Current: $6.01
Upside: +282.70%
Sep 29, 2025
Maintains: Buy
Price Target: $70 → $105
Current: $68.66
Upside: +52.93%
Sep 23, 2025
Maintains: Buy
Price Target: $50 → $44
Current: $45.67
Upside: -3.66%
Sep 15, 2025
Reiterates: Buy
Price Target: $75
Current: $39.84
Upside: +88.25%
Sep 12, 2025
Reiterates: Buy
Price Target: $25
Current: $9.50
Upside: +163.16%
Sep 10, 2025
Reiterates: Buy
Price Target: $8
Current: $2.14
Upside: +273.83%
Aug 13, 2025
Reiterates: Buy
Price Target: $22
Current: $5.87
Upside: +274.79%
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $20
Current: $21.03
Upside: -4.90%